Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ASCO 2022 | Methods for the early diagnosis of pancreatic cancer

Alfredo Carrato • 5 Jun 2022
ASCO 2022
Gastrointestinal Cancer Pancreatic Cancer

Alfredo Carrato, MD, PhD, Hospital Ramón y Cajal, Madrid, Spain, discusses the use of liquid biopsy and a microbiome signature for the early diagnoses of pancreatic cancer. This interview took place at the American Society of Clinical Oncology (ASCO) 2022 Annual Meeting in Chicago, IL.

More from Alfredo Carrato

2:30
Manipulating the microbiome of patients with pancreatic cancer to increase response to treatment
Alfredo Carrato • 5 Jun 2022
0:53
Second-line treatment strategies for pancreatic cancer
Alfredo Carrato • 5 Jun 2022
2:45
SEQUENCE: nab-paclitaxel/gemcitabine with modified FOLFOX in pancreatic cancer
Alfredo Carrato • 5 Jun 2022
2:20
What is the best treatment for RAS wild-type metastatic colorectal cancer?
Alfredo Carrato • 8 Sep 2017

Related Videos

1:53
Important pathophysiological determinants of elevated cirDNA post-surgery
Alain Thierry • 9 Apr 2024
0:47
Emerging molecular drivers and biomarker targets in gastroesophageal cancers
Tatsuhiro Shibata • 9 Apr 2024
0:52
DRP-104 with durvalumab in fibrolamellar hepatocellular carcinoma
Marina Baretti • 9 Apr 2024
1:06
The emerging role of cancer vaccines in treating liver cancer
Marina Baretti • 9 Apr 2024
The content of VJOncology is intended for healthcare professionals